• Share
  • Email
  • Embed
  • Like
  • Private Content
Migraine - Epidemiology Forecast to 2023
 

Migraine - Epidemiology Forecast to 2023

on

  • 81 views

Market Research Reports, Inc. has announced the addition of “EpiCast Report: Migraine - Epidemiology Forecast to 2023” research report to their offering. more information visit: ...

Market Research Reports, Inc. has announced the addition of “EpiCast Report: Migraine - Epidemiology Forecast to 2023” research report to their offering. more information visit: http://mrr.cm/Z4J

Statistics

Views

Total Views
81
Views on SlideShare
81
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Migraine - Epidemiology Forecast to 2023 Migraine - Epidemiology Forecast to 2023 Presentation Transcript

    • Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners. www.MarketResearchReports.com
    • Introduction to Report  Launch Date: February 10, 2014  Number of Pages: 44  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 3,995 Price For Site License: USD 7,990 Price For Global User License: USD 11,985 Delivery Time: Within 24 Hours (During Working Days) www.MarketResearchReports.com
    • About the Report Migraine is typically characterized by recurring headaches, throbbing pain on one side of the head along with one or more of the following symptoms: nausea; vomiting; and increased sensitivity to light, sound and smell (Bigal and Lipton, 2006). Because migraine is one of the most prevalent types of headache, there is a substantial economic and social burden associated with the condition worldwide, and it is therefore recognized as a high-priority public health problem by the World Health Organization (WHO) (Leonardi et al., 2005; Lusic, 2001). The Global Burden of Disease (GBD) study in 2010 ranks migraine as the first among the neurological disorders (Leonardi and Raggi, 2013). www.MarketResearchReports.com
    • Research Findings In 2023, Publisher epidemiologists forecast that the total prevalent cases of migraine in the 7MM remained almost the same, with 75.83 million total prevalent cases in 2013 and 76.38 million total prevalent cases, with an annual growth rate (AGR) of 0.07% in the forecast period. Throughout the forecast period, the US will have the highest number of total prevalent cases of migraine, with 29.61 million total prevalent cases in 2013 and 31.13 million total prevalent cases in 2023. www.MarketResearchReports.com
    • Research Findings Continues.. Publisher epidemiologists obtained total prevalence data for migraine from peer-reviewed journals and populationbased studies in the respective markets and used consistent methodology to ensure comparability of results. Furthermore, Publisher epidemiologists made a meaningful assumption that the age- and sex-specific total prevalence of migraine in the 7MM would remain constant throughout the forecast period because epidemiologic literature suggests relatively stable trends in the prevalence of migraine worldwide, thereby providing a realistic and meaningful forecast for the ageand sex-specific total prevalent cases of migraine in the 7MM. www.MarketResearchReports.com
    • Scope The Migraine EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of migraine in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total prevalent cases of migraine segmented by age (beginning at 18 years and ending at 80 years and older), sex, and the number of total prevalent cases of migraine with aura and without aura in these markets. The migraine epidemiology report is written and developed by Masters- and PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM. www.MarketResearchReports.com
    • Report Coverage 1. Table of Contents 2. Introduction 3. Epidemiology 4. Appendix For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners. www.MarketResearchReports.com
    • Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @ http://www.marketresearchreports.com/idea-center www.MarketResearchReports.com
    • How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: http://www.marketresearchreports.com/globaldata/epic ast-report-migraine-epidemiology-forecast-2023 About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : info@marketresearchreports.com Phone: +1 302-703-7787 (USA) +91-8762746600 (India) www.MarketResearchReports.com